A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
Clinical trial NCT01120184 · COMPLETED
Trial details
- NCT number
- NCT01120184
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-31
- Primary completion
- 2014-09-30
- Enrollment
- 1095
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.